SUMMARY Eight methods for the assay of chloramphenicol in clinical samples were compared with our own modification of a plate diffusion technique using Sarcina lutea and yeast extract agar. Six of the eight methods were less sensitive than originally reported, and five of them were considered unsuitable for use in clinical microbiology practice. The remaining three methods together with the S. lutea/yeast extract modification were used to assay chloramphenicol in 20 samples of serum. Twenty samples of cerebrospinal fluid were also assayed by the S. lutea/yeast extract method. Our results indicate that only the Bacillus subtilis (sensitivity 6-0 mg/l) and the S. lutea (sensitivity 2 5 mg/I) diffusion methods are suitable for use with clinical samples in routine practice. The problems of chloramphenicol toxicity, appropriate dosage regimens, and the need for assay of the drugs are considered.
The liability of chloramphenicol to provoke toxic effects with fatal outcome 2 limits its usefulness, and it is generally reserved for the treatment of some cases of typhoid fever or other serious Gram-negative infections,3 finding application in paediatric, neurological, and neurosurgical practice.
The toxic side effects are enumerated by Wade and Reynolds.4 While irreversible and sometimes fatal aplastic anaemia (incidence 1: 20 000-1:80 000) appears to be idiosyncratic and is, perhaps, genetically determined, depression of the bone marrow and the gray syndrome in premature and other newborn infants are dose related.5 6 Reversible depression of the marrow occurs usually when plasma chloramphenicol concentrations reach [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] mg/I, and the gray syndrome has been reported most frequently in infants given more than 50 mg/kg body weight daily. Reduced doses are advised for those with impaired renal or liver function, but there is little uniformity of view on appropriate dosage regimens for premature and other neonates. Recommendations taking account of prematurity have been made7-9 but it is unlikely that dosage schedules that are both therapeutic and relatively non-toxic can be determined unless plasma and tissue concentrations of the drug can be measured reliably and accurately for each individual.
Received for publication 3 December 1979 A number of methods for the assay of chloramphenicol have been described, with varying claims for their sensitivity, reliability, and accuracy. We have compared eight of them with our own modification of a diffusion method using a minimal medium and Sarcina lutea as indicator organism. This study has been undertaken as part of a wider investigation of the pharmacology of chloramphenicol in premature and immature neonates, the results of which will be reported later.
Material and methods

CHLORAMPHENICOL STANDARDS
Purified chloramphenicol powder (Parke Davis) was used to prepare standards in horse serum (pH 6 Modified trypticase 18 C. perfringens 0-6 ml log phase 4 14 soy agar culture (BBL)* (incorporate) With the addition of 1-0 ml 40 % sheep red blood cells and 0-2 Y. hemin solution (0 5 mg/ml), tIDescribed in this paper. Table 2 summarises the results obtained with standard concentrations of chloramphenicol using the nine methods described. In five instances the methods were less sensitive than reported by the authors, and with only three of the methods tested was it possible to detect reliably less than 10 mg/l. The accuracy of the methods varied considerably; the chemical method and all the diffusion methods except that using Clostridium perfringens gave good results with all the results from standard concentrations on or very close to the line of best fit; the results with C. perfringens and the turbidimetric methods were less satisfactory, with wide discrepancies between duplicate readings giving a less reliable regression line with a resultant loss in accuracy. A 10 mg/I internal standard was included with 10 separate assays using the S. lutea/yeast extract diffusion assay and gave a mean reading of 10-07 mg/l with a range of 9-8-10-3 mg/l, showing that the reproducibility of the method is high.
Results
ASSAY OF CHLORAMPHENICOL STANDARDS
The aliquot required and the time taken for completion of the assay varied considerably. All methods that took less than 18 hours occupied the bench worker for long periods and required constant attention. With the exception of the chemical method, all required daily preparation of cultures and/or assay plates if emergency or out of hours assays were to be performed. Many commercially marketed 14 cm Petri dishes do not have flat bases, making for difficulties when the agar volumes were small, as for example, in the diffusion assay using C. perfringens. Use of 4 x 4 inch (10 x 10 cm) photographic plates instead of plastic dishes resulted in an improved regression line.
ASSAY OF TEST SAMPLES
On grounds of reproducibility and general applicability to routine practice three agar diffusion assays (methods 1, 4, and 5 from Table 1 ) and the chemical method of Kakemi were selected to assay the test samples. All sera were tested by these methods and the results are shown in Table 3 . The S. lutea diffusion method detected chloramphenicol at concentrations of 2-5 mg/l. The minimal detectable concentration with the B. subtilis diffusion assay was 5 mg/l and with the chemical method it was 15 mg/l. Thus while the S. litea method yielded measurable chloramphenicol levels in 18 of 20 samples, the B. subtilis assay detected chloramphenicol in nine and the chemical method in only six of the serum samples tested ( Table 3) .
The results obtained using the C. perfringens rapid diffusion method are also shown in Table 3 . In this case the low sensitivity of the assay was complicated further by the presence of metronidazole in six of the samples tested. The difficulties experienced in obtaining a satisfactory regression line with this assay, the time taken to set it up, and problems in reading the results accurately do not commend it.
The volume of cerebrospinal fluid available for study in all cases was too small for a comparison of methods to be undertaken, and the samples were tested only by the yeast extract/S. lutea diffusion method. The results obtained were in the range < 2 5-15 mg/I.
Discussion
Chloramphenicol is widely used, especially in the treatment of infections of the central nervous system, because of the ease with which it crosses the blood brain barrier and the broad spectrum of its antimicrobial activity. However, the risks of haematological and other side effects cannot be ignored. Reliance on recommended dosage regimens is not sufficient to ensure that toxic side effects will not occur, or that therapeutic concentrations, generally taken to be between 10 and 20 ,hg/ml, will be achieved, for there are wide variations in absorption, distribution, metabolism, and elimination in individuals. The age of the recipient is an important factor,6 and serum concentrations are particularly variable in the newborn, emphasising the need for regular assay of the drug.7 Concomitant phenobarbitone medication may lead to subtherapeutic levels of chloramphenicol after only a few days;21 22 other drugs, such as phenytoin, interact with chloramphenicol,23 although the assertion that combined therapy with penicillin increases the renal excretion rate of chloramphenicol5 is not proven, since the chloramphenicol assay method used by these authors is affected by metabolites of penicillin. Although combined therapy with these two antimicrobial drugs is not recommended they are often used together. If maximal therapeutic effect is to be achieved without toxic effect, determination of the serum concentration of chloramphenicol is deemed to be mandatory.24
The reversible marrow disturbances induced by chloramphenicol are believed to be due to the active component and not to inactive metabolites.6 25 Since the ratio of active to inactive compound in serum shows wide variation, especially in neonates6 where microsomal enzyme systems are underdeveloped and the glomerular filtration rate may be reduced, it is important that therapy should be monitored using a method which detects only the active component. The assay procedure should not be affected by the presence of other antimicrobia drugs.
Most of the methods that we tested produced satisfactory regression lines for reading concentrations up to 50 mg/l. However, their sensitivity varied from 2-5 to 20 mg/I. Toxic side effects of chloramphenicol therapy are thought to be associated with serum levels above 15-20 mg/126 27 SO that it is important that assay procedures should be as sensitive as possible, particularly for neonates where dilution of samples may be necessary to obtain working volumes. In our study, the sensitivity of five of the nine methods tested was less than that reported, greatly reducing the value of the methods. Further, we considered that those methods which failed to produce satisfactory regression lines for the range of standards tested were unsuitable for use in clinical practice. The turbidimetric assays, which fall into this group, were also unsatisfactory because of the variable effect upon the growth of the indicator organism produced by the large volume of sample required. Most antibiotics which interfere with the microbiological assay of chloramphenicol can be selectively removed or inactivated. Metronidazole, present in six of the clinical samples that we tested, cannot. While this drug has no effect on assay systems using aerobic organisms its presence invalidates the rapid diffusion assay using C.
perfringens.
Physical methods for the assay of chloramphenicol using radioactively labelled enzymes,28 gas liquid de Louvois, Mulhall, and Hurley chromatography,29 and high pressure liquid chromatography30 have been described. None of these was used in the present study, but the enzyme methods appear promising as they require only small volumes of serum and are extremely sensitive and specific. However, appropriate acetylating enzymes must be prepared, and a scintillation counter is required. Most chemical and physical methods have a high degree of accuracy and are unaffected by the presence of other antibiotics or other metabolites; an exception is the modified Bratton and Marshall method,3' 32 which is affected by metabolites of penicillin and sulphonamides. Most chemical methods do not distinguish between active drug and inactive metabolites, and since the components may not be present in fixed proportion in biological samples, their value in clinical microbiology is questionable. We used the modified Kakemi method20 because it does not detect esters of chloramphenicol nor the glucuronide or arylamine derivatives.'9 High bilirubin values and lipaemic sera are known to interfere with the reaction. 33 Our investigation suggests that, of nine methods tested, only the diffusion assays using S. lutea/yeast extract agar and B. subtilis are suitable for routine use, although chloramphenicol cannot be measured at less than 6 mg/l with the latter method. The assay using S. lutea/yeast extract agar is sensitive, easy to perform, and reproducible and uses acceptable volumes of sample. We recommend its use in diagnostic practice. 
